Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

kjm_cropped

HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HMNC Brain Health, appointments

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …
Appointment

Study reveals Alzheimer’s spreads differently than previously thought

November 3, 2021 Research and Development

A University of Cambridge research team has used human data to quantify the speed of different processes that lead to …
News

Clinical trial shows promise for aggressive eye cancer treatment

November 3, 2021 Research and Development

A clinical trial with University of Liverpool researchers at The Clatterbridge Cancer Centre has shown great promise for an immunotherapy …
News

Outsourcing in clinical trials: A response to rising challenges

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …
Feature

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …
Feature

Breakthrough status given to Renew Bioscience’s Alzheimer’s treatment

November 3, 2021 Research and Development

Renew Bioscience announced it has received Breakthrough Device Designation status from the FDA for the Cerezen® Device, a novel treatment …
News

Covid jabs more effective than virus at preventing infection

November 3, 2021 Research and Development

A US study has revealed that the immunity received from COVID-19 vaccines is much stronger than that stimulated by infection …
News
beverley-carr-enhanced

Beverley Carr appointed Chief Business Officer for Amphista Therapeutics

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …
Appointment

Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, mogrify

Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …
Appointment

Plan C COVID strategy being discussed by government

October 27, 2021 Research and Development

An advisor to the Department of Health told MPs a ‘Plan C’ has been mentioned in Government discussions, should the …
News

Quell Therapeutics receives CTA approval to begin first clinical trial with a multi-modular engineered treg cell company

October 27, 2021 Research and Development

The MHRA has approved Quell Therapeutics’ first clinical trial for its lead cell therapy candidate QEL-001. This approval paves the …
News

Study finds link between COVID-19 infection and neurological complications

October 27, 2021 Research and Development

A study conducted by Nature Medicine has revealed an increased risk of Guillain-Barre Syndrome (GBS) and Bell’s palsy following a …
News

FDA and EMA approve Novartis’ treatment for follicular lymphoma patients

October 27, 2021 Research and Development

The FDA and EMA have accepted Novartis’ Supplemental Biologics License Application (sBLA) and Type II Variation for KymriahⓇ in patients …
News

IXICO partner with Microsoft to enhance AI platform

October 20, 2021 Research and Development

IXICO, an AI data analytics company delivering insights into neuroscience, have announced a collaboration with Microsoft to develop its AI …
News

Synairgen COVID-19 treatment moves to Phase III trials

October 20, 2021 Research and Development

Synairgen PLC have said that its anti-viral treatment for severe lung infections is advancing to the final stage of clinical …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025